MaxCyte (MXCT) Stock Price, Quote, News & History

Comments

MaxCyte Inc (MXCT) Stock Price, Quote, News & History

MXCTNASDAQ

Trade with Public

$0.7674

0.00720.95%

At close: Mar 4, 4:00 PM EST

$0.7672

-0.0002-0.03%

After Hours: 4:56 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.75

Close

$0.77

Volume / Avg.

965.34K / 1.24M

Day Range

$0.75 - $0.78

52 Wk Range

0.64 - 3.58

Market Cap

$81.84M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

4.8%

Days to Cover

2.95

Recent MaxCyte Inc News

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

MarketBeat Week in Review – 01/20 - 01/24

Stocks rallied sharply this week, with the S&P 500 index hitting a new all-time high. One reason for the bullish sentiment was clarity about the Trump administration's initial tariff proposals, which are not as

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.54M

Investing Cash Flow (TTM)

14.59M

Financing Cash Flow (TTM)

963.00K

Free Cash Flow (TTM)

-41.23M

Capital Expenditure (TTM)

-1.68M

Net Change in Cash (TTM)

-23.99M

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$553.01K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.37

PB Ratio (TTM)

0.45

Earnings Yield % (TTM)

-56.03%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.69

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.97M

Debt to Equity

0.10

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.75

Close

$0.77

Volume / Avg.

965.34K / 1.24M

Day Range

$0.75 - $0.78

52 Wk Range

0.64 - 3.58

Market Cap

$81.84M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

4.8%

Days to Cover

2.95

About

Sector

Health Care

Industry

Life Sciences Tools & Services

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and developme...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy MaxCyte (MXCT) stock?

A

You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are MaxCyte (MXCT) competitors?

A

Other companies in MaxCyte’s space includes: Harvard Bioscience Inc (NASDAQ:HBIO), Codexis Inc (NASDAQ:CDXS), Quantum-Si Inc (NASDAQ:QSI), Inotiv Inc (NASDAQ:NOTV) and Lifecore Biomedical Inc (NASDAQ:LFCR).

Q

What is the forecast, or price target, for MaxCyte (MXCT) stock?

A

MaxCyte has a consensus price target of $8.25.

Q

What is the current price for MaxCyte (MXCT)?

A

The stock price for MaxCyte (NASDAQ: MXCT) is $0.7672 last updated March 4, 2026 at 4:56 PM EST.

Q

Does MaxCyte (MXCT) pay a dividend?

A

There are no upcoming dividends for MaxCyte.

Q

When is MaxCyte (NASDAQ:MXCT) reporting earnings?

A

MaxCyte does not have any upcoming earnings scheduled.

Q

Is MaxCyte (MXCT) going to split?

A

There is no upcoming split for MaxCyte.

Q

What sector and industry does MaxCyte (MXCT) operate in?

A

MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch

Harvard Bioscience Inc

Lifecore Biomedical Inc

NASDAQ:LFCR

$7.09

0.42%

Atlantic International Corp

Standard BioTools Inc

NASDAQ:LAB

$1.10

3.77%

Key Statistics

Open

$0.75

Close

$0.77

Volume / Avg.

965.34K / 1.24M

Day Range

$0.75 - $0.78

52 Wk Range

0.64 - 3.58

Market Cap

$81.84M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

4.8%

Days to Cover

2.95

Recent MaxCyte Inc News

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

MarketBeat Week in Review – 01/20 - 01/24

Stocks rallied sharply this week, with the S&P 500 index hitting a new all-time high. One reason for the bullish sentiment was clarity about the Trump administration's initial tariff proposals, which are not as

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.54M

Investing Cash Flow (TTM)

14.59M

Financing Cash Flow (TTM)

963.00K

Free Cash Flow (TTM)

-41.23M

Capital Expenditure (TTM)

-1.68M

Net Change in Cash (TTM)

-23.99M

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$553.01K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.37

PB Ratio (TTM)

0.45

Earnings Yield % (TTM)

-56.03%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.69

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.97M

Debt to Equity

0.10

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.75

Close

$0.77

Volume / Avg.

965.34K / 1.24M

Day Range

$0.75 - $0.78

52 Wk Range

0.64 - 3.58

Market Cap

$81.84M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

4.8%

Days to Cover

2.95

About

Sector

Health Care

Industry

Life Sciences Tools & Services

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and developme...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry